Henry N Jabbour Selected Research

prostaglandin F2alpha receptor

1/2011	Chemokine (C-C) motif ligand 20 is regulated by PGF(2α)-F-prostanoid receptor signalling in endometrial adenocarcinoma and promotes cell proliferation.
9/2010	PGF2α-F-prostanoid receptor signalling via ADAMTS1 modulates epithelial cell invasion and endothelial cell function in endometrial cancer.
1/2010	F-Prostaglandin receptor regulates endothelial cell function via fibroblast growth factor-2.
1/2010	Interleukin-11 in endometrial adenocarcinoma is regulated by prostaglandin F2alpha-F-prostanoid receptor interaction via the calcium-calcineurin-nuclear factor of activated T cells pathway and negatively regulated by the regulator of calcineurin-1.
12/2009	Prostaglandin F(2alpha)-F-prostanoid receptor regulates CXCL8 expression in endometrial adenocarcinoma cells via the calcium-calcineurin-NFAT pathway.
3/2008	Prostaglandin E2 and F2alpha activate the FP receptor and up-regulate cyclooxygenase-2 expression via the cyclic AMP response element.
8/2007	F-prostanoid receptor regulation of fibroblast growth factor 2 signaling in endometrial adenocarcinoma cells.
11/2005	A positive feedback loop that regulates cyclooxygenase-2 expression and prostaglandin F2alpha synthesis via the F-series-prostanoid receptor and extracellular signal-regulated kinase 1/2 signaling pathway.
9/2005	A novel angiogenic role for prostaglandin F2alpha-FP receptor interaction in human endometrial adenocarcinomas.
2/2004	Expression, localization, and signaling of prostaglandin F2 alpha receptor in human endometrial adenocarcinoma: regulation of proliferation by activation of the epidermal growth factor receptor and mitogen-activated protein kinase signaling pathways.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Henry N Jabbour Research Topics

Disease

19	Adenocarcinoma 01/2012 - 01/2002
9	Neoplasms (Cancer) 01/2011 - 12/2004
7	Carcinogenesis 05/2011 - 02/2004
6	Carcinoma (Carcinomatosis) 08/2007 - 01/2002
5	Hypoxia (Hypoxemia) 08/2011 - 02/2006
3	Inflammation (Inflammations) 08/2011 - 05/2010
3	Endometrial Neoplasms (Endometrial Cancer) 09/2010 - 09/2009
2	Infections 01/2012 - 12/2011
2	Ectopic Pregnancy 01/2011 - 11/2010
2	Menorrhagia 06/2006 - 11/2003
2	Endometriosis 06/2006 - 11/2003
1	Uterine Cervical Neoplasms (Cancer of the Cervix) 10/2012
1	Obesity 08/2010
1	Adenoma (Adenomas) 08/2007
1	Colorectal Neoplasms (Colorectal Cancer) 08/2007
1	Hyperalgesia 03/2007
1	Infertility (Sterility) 02/2007
1	Prostatic Neoplasms (Prostate Cancer) 02/2007
1	Dysmenorrhea (Menstrual Pain) 06/2006
1	Tuberous Sclerosis 2 12/2004
1	Neoplasm Metastasis (Metastasis) 11/2003
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2002

Drug/Important Bio-Agent (IBA)

20	ProstaglandinsIBA 08/2011 - 11/2003
10	prostaglandin F2alpha receptorIBA 01/2011 - 02/2004
9	Proteins (Proteins, Gene)FDA Link 08/2011 - 01/2002
7	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 01/2012 - 01/2002
7	Messenger RNA (mRNA)IBA 08/2011 - 09/2005
7	Prostaglandins FIBA 08/2011 - 02/2004
6	EnzymesIBA 01/2012 - 11/2003
6	Prostaglandins EIBA 05/2011 - 06/2004
5	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2012 - 06/2004
4	Progesterone FDA LinkGeneric 08/2011 - 08/2010
4	DinoprostIBA 09/2009 - 02/2004
3	Complementary DNA (cDNA)IBA 05/2011 - 11/2005
3	Dinoprostone (PGE2)FDA Link 03/2011 - 12/2002
3	CalcineurinIBA 01/2011 - 12/2009
3	LigandsIBA 01/2011 - 12/2009
3	ErbB Receptors (EGF Receptor)IBA 07/2006 - 02/2004
2	Interleukin-8 (Interleukin 8)IBA 10/2012 - 03/2011
2	ChemokinesIBA 10/2012 - 09/2010
2	LipopolysaccharidesIBA 01/2012 - 12/2011
2	LipoxinsIBA 08/2011 - 07/2011
2	Prostaglandin E Receptors (Prostaglandin E Receptor)IBA 05/2011 - 01/2002
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2011 - 09/2010
2	Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA 01/2010 - 08/2007
2	CalciumIBA 01/2010 - 12/2009
2	Gonadotropin-Releasing Hormone (GnRH)FDA Link 03/2007 - 02/2007
1	Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA 01/2012
1	InterleukinsIBA 01/2012
1	CytokinesIBA 01/2012
1	MicroRNAs (MicroRNA)IBA 12/2011
1	Annexin A1IBA 07/2011
1	EP4 Subtype Prostaglandin E ReceptorsIBA 05/2011
1	Progestins (Progestagens)IBA 03/2011
1	Biomarkers (Surrogate Marker)IBA 01/2011
1	CC ChemokinesIBA 01/2011
1	Chemokine CCL20IBA 01/2011
1	NFATC Transcription FactorsIBA 01/2011
1	CotinineIBA 11/2010
1	Metalloproteases (Metalloproteinases)IBA 09/2010
1	DisintegrinsIBA 09/2010
1	ThrombospondinsIBA 09/2010
1	Conditioned Culture MediaIBA 01/2010
1	Protein Isoforms (Isoforms)IBA 01/2010
1	ImmunosorbentsIBA 01/2010
1	Interleukin-11 (Interleukin 11)IBA 01/2010
1	Protein Kinase CIBA 12/2009
1	CXC ChemokinesIBA 12/2009
1	Estrogen Receptor betaIBA 09/2009
1	Progesterone Receptors (Progesterone Receptor)IBA 09/2009
1	Estrogen Receptor alphaIBA 09/2009
1	Chemokine CXCL1IBA 07/2009
1	Interleukin-8B ReceptorsIBA 07/2009
1	Fibroblast Growth Factor Receptors (Fibroblast Growth Factor Receptor)IBA 08/2007
1	Fibroblast Growth Factors (Fibroblast Growth Factor)IBA 08/2007
1	Hormones (Hormone)IBA 02/2007
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 07/2006
1	Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA 07/2006
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 07/2006
1	Transcription Factors (Transcription Factor)IBA 02/2006
1	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 12/2004
1	Tuberous Sclerosis Complex 2 ProteinIBA 12/2004
1	Mitogen-Activated Protein Kinase 3IBA 06/2004
1	Mitogen-Activated Protein KinasesIBA 02/2004
1	Type C PhospholipasesIBA 02/2004
1	Inositol PhosphatesIBA 02/2004
1	Prostaglandin Receptors (Prostaglandin Receptor)IBA 11/2003
1	Doxycycline (Periostat)FDA LinkGeneric 01/2002
1	Cyclooxygenase 1IBA 01/2002
1	RNA (Ribonucleic Acid)IBA 01/2002

Therapy/Procedure

2	Therapeutics 05/2010 - 02/2007
1	Hormone Replacement Therapy (Therapy, Hormone Replacement) 08/2010